An Observational Study of Coronary Microvascular Disease of China

NCT06676137 · tracked via the Priya Life Science China tracker

Sponsor

Henan Institute of Cardiovascular Epidemiology

Phase

Observational

Started

2024-11-11

Last updated

2025-08-20

Condition(s) studied

Coronary Microvascular Disease

Study summary

Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.

Eligibility

Sex

ALL

Min age

18 Years

Max age

85 Years

Healthy volunteers

Inclusion Criteria: 1. Angina symptoms 2. Objective evidence of myocardial ischemia 3. Coronary angiography was normal,irregular tube wall, or stenosis \<50% Exclusion Criteria: 1. People under the age of 18 2. Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease

Primary outcome measure(s)

Establish a Registry of CMD patients in China — 5 years

Trial sites (1)

Facility	City	Region	Status
Fuwai central China cardiovascular hospotial	Zhengzhou	China	Recruiting

More Henan Institute of Cardiovascular Epidemiology trials in China

Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden Recruiting

CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD Recruiting

Influencing Factors and Outcomes of DCB Angioplasty Enrolling by invitation

Effects of Long-term Remote Ischemic Preconditioning on Clinical Outcome in Patients With Acute Myocardial Infarction Recruiting

Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After CABG Recruiting

Other trials for the same condition

Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease Starting soon

Qishenyiqi Dripping Pill for Coronary Microvascular Disease Recruiting

A Clinical Study of Fundus OCTA for the Identification of CMD Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06676137 on ClinicalTrials.gov ↗ ← All trials in China